$330 Million is the total value of Nextech Invest Ltd.'s 14 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 7.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | $133,958,163 | +3.5% | 4,839,529 | 0.0% | 40.59% | -7.8% | |
| New | TANGO THERAPEUTICS INC | $62,312,615 | – | 5,533,980 | +100.0% | 18.88% | – | |
| TYRA BIOSCIENCES INC | $34,680,874 | -19.1% | 2,518,582 | 0.0% | 10.51% | -27.9% | ||
| EQRX INC | $29,091,821 | +19.4% | 13,104,424 | 0.0% | 8.82% | +6.4% | ||
| ORIC | ORIC PHARMACEUTICALS INC | $25,928,570 | -22.0% | 4,285,714 | 0.0% | 7.86% | -30.5% | |
| CGEM | CULLINAN ONCOLOGY INC | $11,051,362 | -15.9% | 1,221,145 | 0.0% | 3.35% | -25.0% | |
| RLAY | Buy | RELAY THERAPEUTICS INC | $10,061,800 | -15.6% | 1,196,409 | +26.1% | 3.05% | -24.7% |
| SBTX | ARS PHARMACEUTICALS INC | $7,219,910 | -43.6% | 1,910,029 | 0.0% | 2.19% | -49.7% | |
| ARVN | ARVINAS INC | $5,641,610 | -20.9% | 287,251 | 0.0% | 1.71% | -29.5% | |
| KNTE | KINNATE BIOPHARMA INC | $3,261,272 | -53.8% | 2,329,480 | 0.0% | 0.99% | -58.8% | |
| PMVP | Sell | PMV PHARMACEUTICALS INC | $2,586,684 | -12.3% | 421,284 | -10.6% | 0.78% | -21.8% |
| KRON | KRONOS BIO INC | $1,886,998 | -24.4% | 1,451,537 | 0.0% | 0.57% | -32.6% | |
| THESEUS PHARMACEUTICALS INC | $1,644,424 | -71.2% | 611,310 | 0.0% | 0.50% | -74.3% | ||
| CCCC | C4 THERAPEUTICS INC | $699,094 | -32.4% | 375,857 | 0.0% | 0.21% | -39.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| REVOLUTION MEDICINES INC | 8 | Q3 2023 | 44.0% |
| EQRX INC | 8 | Q3 2023 | 23.5% |
| TYRA BIOSCIENCES INC | 8 | Q3 2023 | 16.9% |
| KINNATE BIOPHARMA INC | 8 | Q3 2023 | 14.0% |
| CULLINAN ONCOLOGY INC | 8 | Q3 2023 | 5.3% |
| PMV PHARMACEUTICALS INC | 8 | Q3 2023 | 8.4% |
| ARVINAS INC | 8 | Q3 2023 | 6.2% |
| SILVERBACK THERAPEUTICS INC | 8 | Q3 2023 | 6.5% |
| KRONOS BIO INC | 8 | Q3 2023 | 5.2% |
| THESEUS PHARMACEUTICALS INC | 8 | Q3 2023 | 2.3% |
View Nextech Invest Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-01 |
| 13F-HR/A | 2022-05-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Nextech Invest Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.